Features of patients who received chemotherapy for breast cancer

Shamrai, Volodymyr Anatoliiovych; Misiurko, Oles Ivanovych; Grebeniuk, Dmytro Ihorovych

dc.contributor.author	Shamrai, Volodymyr Anatoliiovych
dc.contributor.author	Misiurko, Oles Ivanovych
dc.contributor.author	Grebeniuk, Dmytro Ihorovych
dc.date.accessioned	2025-04-28T15:50:28Z
dc.date.available	2025-04-28T15:50:28Z
dc.date.issued	2021
dc.identifier.citation	Shamrai V. A. Features of patients who received chemotherapy for breast cancer / V. A. Shamrai, O. I. Misiurko, D. I. Grebeniuk // Proceedings of VII International Scientific and Practical Conference “Modem directions of scientific research development” (Chicago, USA, December 22-24, 2021). – Chicago: BoScience Publisher, 2021. – P. 80-85.	uk_UA
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/9812
dc.description.abstract	Results of the analysis of the data of 1504 patients who received chemotherapy for breast cancer in the Podillian Regional Oncology Center during 2015-2017 are presented in this article. A detailed analysis of the characteristics of this contingent of patients was carried out. A detailed analysis of data showed that the proportion of women of childbearing age who received chemotherapy as part of comprehensive treatment is 19.93% of all new cases. Among patients receiving chemotherapy, this figure was 28.79%. The most common chemotherapy regimen used in the study contingent was the CAF regimen, which included Cyclophosphamide, Doxorubicin, and 5-Fluorouracil.	uk_UA
dc.language.iso	en_US	uk_UA
dc.publisher	BoScience Publisher	uk_UA
dc.subject	breast cancer	uk_UA
dc.subject	Podillian Regional Oncology Center	uk_UA
dc.subject	diagnosis	uk_UA
dc.subject	treatment	uk_UA
dc.subject	chemotherapy	uk_UA
dc.title	Features of patients who received chemotherapy for breast cancer	uk_UA
dc.type	Thesis	uk_UA